nn
" The Voice Of Interventional Pain Management "

celebrating our 10th anniversary
 

June 5, 2013

 

  1. Physician Wanted

journalPain Physician Names Dr. Joshua A. Hirsch New Editor in Chief

 

The American Society of Interventional Pain Physicians takes pleasure in announcing that Joshua A. Hirsch, M.D. FACR, FSIR, Vice Chief--Interventional Care, Chief-- Minimally Invasive Spine Surgery, Service Line Chief--Interventional Radiology, Director-- Neuroendovascular Program, at the Massachusetts General Hospital; and Associate Professor, Harvard Medical School has accepted the position of Editor-in-Chief of Pain Physician.

 

 Dr. Hirsch , the unanimous choice of the Executive Committee is an outstanding person for this role. He is an author of more than two hundred peer reviewed manuscripts, numerous book chapters and has edited several books. Most cogently, Dr. Hirsch was a founding editor of the Journal of NeuroInterventional Surgery.

 

Dr. Hirsch is recognized for his service to organized medicine and has been voted into leadership roles in a variety of professional societies. He is the immediate Past President of the Society of NeuroInterventional Surgery and has served many years on the Board of the American Society of Spine Radiology. He was been elected multiple times into the leadership of ASIPP where he currently serves as Director Emeritus. This year, he once again helped lead the international GRIBOI meeting.

 

For many years, Dr. Hirsch has been acknowledged as one of America's "Top Doctors" and one of Boston's "Top Doctors" He has been awarded the "Pioneer" award by the Society of Vascular Interventional Neurology and was recently appointed to the Medical Advisory Board of the Niekro Foundation.

 

When accepting this appointment, Dr. Hirsch said, "I am both honored and humbled to have been chosen to serve as the next Editor in Chief of Pain Physician. The progress of this journal has been exceptional. Most recently, the journal has achieved a 2011 impact factor of 10.77. The future offers the opportunity of even greater growth and achievement."

 

 

  Dr. Laxmaiah Manchikanti, Chairman of the Board and Chief Executive Officer of ASIPP Manchikanti stated: "We are so fortunate for Pain Physician to be forwarding into the future under the direction of Josh. The entire interventional pain management community knows Josh as a prolific writer who has participated on many projects related to interventional pain management and worked tirelessly to improve the stature of the Pain Physician. It is admirable that Josh has accepted Editor-in-Chief's position despite his enormous obligations as Vice Chief of Minimally invasive Spine Surgery at Massachusetts General Hospital and Harvard Medical School. I am quite certain that Pain Physician will reach even higher levels as high as the Everest under the direction of Josh. The entire community of interventional pain management is here to congratulate him and extend assistance as we move forward."

 

 

 Incoming President Hans Hansens added " On behalf of the Pain Physician Journal, its editors, and staff, we would like to welcome the appointment of Josh Hirsch, M.D. An active clinician and long standing member of the American Society of Interventional Pain Physicians, he is well respected in the academic community. His contributions will be valuable, and far reaching.

 

We again express our sadness over the passing of Dr. Smith. His shoes will be difficult to fill, but I am confident that Dr. Smith would agree, Dr. Hirsch will be an excellent contribution to the journal, and we look forward to assisting him in any way we can to ensure Pain Physician Journal remains the highest quality and respected publication in our specialty. "

board2013 Board Review Course set for July 29-Aug. 2 in St. Louis, MO

 

   Make plans today to attend teh 2013 Board Review Course set for July 29-Aug. 2 at the Chase Park Plaza in St. Louise, MO.

 

This intensive and comprehensive high-quality review will prepare physicians appearing for the American Board of Medical Specialties (ABMS)-Subspecialty Pain Medicine examination and for the American Board of Interventional Pain Physicians (ABIPP)-Part 1 examination.

 

 

* A five-day review covering anatomy, physiology, pharmacology, psychology, ethics, interventional techniques, non-interventional techniques, controlled substances and practice management

* 39 unique lectures by experts in the field

* Participants can earn up to 44.25 AMA PRA Category 1 Credits

* Extensive educational materials

* Extensive evaluation sessions with daily pre-test, post-test, and review questions

 

 

You can earn up to 44.25 AMA PRA Category 1 credits.

 

Click HERE to Register:  

 

Click HERE for Chase Park Plaza. Special ASIPP room rate through July 7, 2013.

 

 

Click HERE to view Brochure:

pain ASIPP to Offer Pain and Addiction Management Course in July

 

 

 

Register today to attend the Pain and Addiction Mangement review course set for July 29-30 in St. Louis, MO.

 

Registration:

 

ASIPP Special Room Rates through July 7

 

Chase Park Plaza:

houseHouse Passes 'Track and Trace' Drug Bill

 

WASHINGTON -- The House passed a bill late Monday that would require drugs be electronically tracked through the distribution system, but some industry insiders say it still doesn't go far enough to meaningfully detect counterfeiting.

 

H.R. 1919, the Safeguarding America's Pharmaceuticals Act, would create a national system in which manufacturers, distributors, and pharmacies would "track and trace" drug products through the supply chain, a system supporters say is needed to help detect and prevent stolen products, counterfeiting, and re-entry of adulterated drugs into the supply chain.

 

 MedPage Today

adhdNo Link Found Between ADHD Drugs, Future Substance Abuse

 

Children with attention-deficit hyperactivity disorder (ADHD) are far more likely than their peers to engage in serious substance abuse as teens and adults.

 

But do ADHD meds contribute to the risk?

 

In the most comprehensive research ever on this topic, UCLA psychologists found that children with ADHD who take medications such as Ritalin and Adderall are at no greater risk of using alcohol, marijuana, nicotine or cocaine later in life than kids with ADHD who don't take these medications.

 

PsychCentral

blacksBlacks Are Singled Out for Marijuana Arrests, Federal Data Suggests

 

WASHINGTON - Black Americans were nearly four times as likely than whites to be arrested on charges of marijuana possession in 2010, even though the two groups used the drug at similar rates, according to new federal data.

 

This disparity had grown steadily from a decade before, and in some states, including Iowa, Minnesota and Illinois, blacks were around eight times as likely to be arrested.

 

During the same period, public attitudes toward marijuana softened and a number of states decriminalized its use. But about half of all drug arrests in 2011 were on marijuana-related charges, roughly the same portion as in 2010.

 

NY Times

medicareMedicare Fund Future Still Grim

 

The Medicare program's current forecast is slightly less bleak than last year's, but the fund is headed for insolvency in 2026, say the trustees of the Medicare's Hospital Insurance Trust Fund.

 

This isn't exactly dance-in-the-street news but the federal Medicare program is heading for insolvency at a slightly slower pace than previously forecast.

 

Thanks to lower projected spending, lower projected Medicare Advantage program costs, and some technical changes in calculating projections, Medicare's Hospital Insurance Trust Fund will remain solvent until 2026, the 2013 Medicare Trustees Report shows. That's two years longer than the 2012 report estimated.

 

 

Health Leaders Media

steroidsMore Infections Linked to Tainted Steroids

 

The CDC said it has now received reports of 20 infections in three states linked to injectable steroids distributed by a Tennessee compounding pharmacy, but none involved fungal meningitis.

 

Most of the 20 patients have developed skin and soft-tissue infections after receiving injections of methylprednisolone acetate supplied by Main Street Family Pharmacy in Newbern, Tenn., the CDC said Thursday. The cases have been seen in Florida, North Carolina, and Illinois.

 

"To date, no reports of meningitis or other life-threatening infections have been reported," the agency said in a statement.

 

The FDA had announced last week that the pharmacy was recalling

 

MedPage Today

docsDocs Await ACA Compliance Rules

 

Physicians are required to develop and maintain a compliance program in their practice under the Affordable Care Act (ACA), a burden some health policy experts say could be a heavy one for some practices.

 

However, the federal government has yet to release guidelines on what these compliance programs should look like under the 2010 health reform law, creating conflict for doctors on what to do next.

 

Section 6401 of the ACA -- an often-forgotten provision -- requires that all providers and suppliers, regardless of their size, institute formal compliance programs. New practices will no longer be able to enroll in Medicare or Medicaid without a compliance program in place, and already existing practices also will be expected to institute them.

 

 

MedPage Today

cdcCDC: Injection Guidelines Target Safety

 

 

With the stated goal of increasing injection safety, the CDC unveiled a new set of guidelines powered by a catchy phrase -- "the four Es" and then worked to tailor a set of clunky descriptions phrase.

The "Es" in question are:

  • Epidemiologic surveillance of unsafe injection
  • Education
  • Enforcement of safe practices
  • Engineering devices to reduce risks

Among safe injection practices that help prevent the spread of disease, healthcare professionals should never administer medications from the same syringe or single-dose vial to multiple patients, nor should they enter a vial with a used syringe or needle, wrote Joseph Perz, DrPH, of the CDC, and co-authors online in Morbidity and Mortality Weekly Report.

 

 

MedPage Today

doorsAs 'Emergency' Doors Close More Seek Care

 

One in five adults in the U.S. sought emergency department treatment at least once during 2011, according to an annual report from the CDC.

 

"Although the percentage of Americans visiting the emergency department each year is stable, the total number of visits to emergency departments increased 34% between 1995 and 2010 (from 97 million to 130 million visits)," stated the agency in Health, United States, 2012.

 

"At the same time, the supply of emergency departments has declined by about 11% to 3,700 emergency departments in 2010," the report noted.

 

The results have been problems such as crowding, delays in treatment, patient dissatisfaction, and worse outcomes.

 

MedPage Today

oxyHow OxyContin's Pain Relief Built 'A World Of Hurt'

 

Prescription painkillers are among the most widely used drugs in America. In the decade since New York Times reporter Barry Meier began investigating their use and abuse, he says he has seen the number of people dying from overdoses quadruple - an increase Meier calls "staggering."

 

"The current statistic is that about 16,000 people a year die of overdoses involving prescription narcotics. ... It's a huge problem. The number of people dying from these drugs is second only to the number of people that die in car accidents," he tells Fresh Air's Terry Gross.

 

NPR

 

 

 


All contents Copyright © 2008
American Society of Interventional Pain Physicians ®
81 Lakeview Drive, Paducah, KY 42001
Phone 270.554.9412, Fax 270.554.5394
E-mail asipp@asipp.org